ARTICLE | Distillery Therapeutics
Ophthalmic disease
March 15, 2017 3:33 PM UTC
Mouse studies suggest inhibiting NRL expression in photoreceptors using CRISPR/Cas9 could help treat retinitis pigmentosa. In healthy mice, subretinal injection of CRISPR/Cas9 targeting NRL knocked do...
BCIQ Company Profiles
BCIQ Target Profiles